Showing results (281-290 of 11,530) with videos related to
Sort By:
Pageof 1,153
British Journal of Clinical Pharmacology|August 1, 1987
Effect of arachidonic acid on anthralin inflammationC M Lawrence, S ShusterBritish Journal of Clinical Pharmacology|March 16, 2022
Are patients living far from hospital at higher risk of late adjuvant chemotherapy for colon cancer?Thomas Vermeulin, Hana Lahbib, Mélodie Lucas, et al.British Journal of Clinical Pharmacology|March 18, 2022
5-α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population-based cohort studyHenok Tadesse Ayele, Antonios Douros, Kristian B FilionBritish Journal of Clinical Pharmacology|April 19, 2022
Plasma levels of VEGF-A and VCAM-1 as predictors of drug-induced hypertension in patients treated with VEGF pathway inhibitorsJulia C F Quintanilha, Kelli Hammond, Yingmiao Liu, et al.British Journal of Clinical Pharmacology|August 1, 1986
Dose determinants of rebound insomniaT A Roehrs, F J Zorick, R M Wittig, et al.British Journal of Clinical Pharmacology|March 23, 2022
Incidence of allopurinol-induced severe cutaneous adverse drug reaction in MalaysiaWei Leik Ng, Kheng Seang Lim, Vidhya Hariraj, et al.British Journal of Clinical Pharmacology|October 19, 2021
Enhanced elimination of betamethasone in dichorionic twin pregnanciesGrazielle de Fátima Pinto Rodrigues, Jhohann Richard de Lima Benzi, Luísa Helena de Castro Matos, et al.British Journal of Clinical Pharmacology|October 27, 2021
Aspirin effects on platelet gene expression are associated with a paradoxical, increase in platelet functionRachel A Myers, Thomas L Ortel, Alexander Waldrop, et al.British Journal of Clinical Pharmacology|January 1, 1986
Once a day verapamil in essential hypertensionF B Müller, H R Ha, H Hotz, et al.British Journal of Clinical Pharmacology|January 1, 1986
Studies on verapamil in the treatment of essential hypertension: a reviewK Midtbø, O Hals, O Lauve, et al.Pageof 1,153